The Prognostic Value of Troponin in Pediatric Polytrauma

Christian Karl Braun1, Annika Schaffer2, Birte Weber2

  • 1Institute of Clinical and Experimental Trauma-Immunology, University Hospital of Ulm, Ulm, Germany.

Frontiers in Pediatrics
|December 12, 2019
PubMed

Insights

Elevated troponin T (TnT) levels in pediatric trauma patients may predict injury severity and mortality. This finding could aid in assessing outcomes for severely injured children.

Area of Science:

  • Pediatric Emergency Medicine
  • Trauma Surgery
  • Clinical Diagnostics

Background:

  • Severe trauma is a leading cause of death in children and adolescents.
  • Troponin T (TnT) has established prognostic value in adult trauma, but data in pediatric polytrauma (PT) are limited.

Purpose of the Study:

  • To investigate the prognostic value of serum troponin T (TnT) levels upon hospital admission in pediatric polytrauma (PT) patients.
  • To explore the association of TnT levels with injury severity, organ dysfunction, and mortality in this population.

Main Methods:

  • Retrospective analysis of 88 pediatric polytrauma patients admitted to a single center.
  • Measurement of troponin T (TnT), interleukin-6 (IL-6), creatine kinase (CK) activity, and lactate.
  • Stratification by Injury Severity Score (ISS) and assessment of organ dysfunction (SOFA score).

Main Results:

  • Significantly increased TnT levels were observed in severe PT patients compared to mild/moderate trauma.
  • Elevated TnT correlated with higher IL-6, CK activity, prolonged ICU stay, chest trauma, lung contusion, organ dysfunction, and fatal outcomes.
  • TnT levels did not correlate with absolute ISS values.

Conclusions:

  • Serum troponin T (TnT) evaluation on admission may assist in predicting injury severity and mortality in pediatric trauma patients.
  • TnT could serve as a valuable prognostic marker, complementing existing parameters in the management of multiply injured children.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
725
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
165
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
222
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
486